Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loperamide for Dehydration Prevention in Ileostomy Patients
NCT02263365Phase 3Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Oct 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loperamide in dehydration, sponsored by Cedars-Sinai Medical Center. Started Oct 2014; status: terminated.
02
Drugs
loperamide
03
Conditions
dehydration
Beyond the preview
Go deeper on NCT02263365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263365.